@book{:/content/books/9789210046527,
  title = {Contraceptive Use by Method 2019},
  author = {Unies, Nations},
  date = {2019},
  publisher = {{United Nations}},
  url = {https://www.un-ilibrary.org/content/books/9789210046527},
  urldate = {2023-05-08},
  abstract = {This data booklet highlights estimates of the prevalence of individual contraceptive methods based on the World Contraceptive Use 2019 (which draws from 1,247 surveys for 195 countries or areas of the world) and additional tabulations obtained from microdata sets and survey reports. The estimates are presented for female and male sterilisation, intrauterine device (IUD), implant, injectable, pill, male condom, withdrawal, rhythm and other methods combined.}
}

@article{abbeMaleContraception2020,
  title = {Male {{Contraception}}},
  author = {Abbe, Carmen R. and Page, Stephanie T. and Thirumalai, Arthi},
  date = {2020-09-30},
  journaltitle = {The Yale Journal of Biology and Medicine},
  shortjournal = {Yale J Biol Med},
  volume = {93},
  number = {4},
  eprint = {33005125},
  eprinttype = {pmid},
  pages = {603--613},
  issn = {0044-0086},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513428/},
  urldate = {2023-03-15},
  abstract = {Unintended pregnancy is a global public health problem. Despite a variety of female contraceptive options, male contraceptive options are limited to the condom and vasectomy. Condoms have high failure rates and surgical vasectomy is not reliably reversible. There is a global need and desire for novel male contraceptive methods. Hormonal methods have progressed the furthest in clinical development and androgen plus progestin formulations hold promise as a marketable, reversible male contraceptive over the next decade. Investigators have tested androgen plus progestin approaches using oral, transdermal, subdermal, and injectable drug formulations and demonstrated the short-term safety and reversibility of hormonal male contraception. The most commonly reported side effects associated with hormonal male contraception include weight gain, acne, slight suppression of serum high-density cholesterol, mood changes, and changes in libido. Efficacy trials of hormonal male contraceptives have demonstrated contraceptive efficacy rates greater than that of condoms. Although there has been less progression in the development of nonhormonal male contraceptives, potentially reversible vaso-occlusive methods are currently in clinical trials in some countries. Various studies have confirmed both men and women’s desire for novel male contraceptives. Barriers to development include an absence of investment from pharmaceutical companies, concerns regarding side effects and spermatogenic rebound with hormonal methods, and lack of clear reversibility and proven effectiveness of nonhormonal methods. The ultimate availability of male contraceptives could have an important impact on decreasing global unintended pregnancy rates (currently 40\% of all pregnancies) and will be a step towards reproductive justice and greater equity in family planning.},
  pmcid = {PMC7513428},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\993XSE8J\\Abbe et al. - 2020 - Male Contraception.pdf}
}

@book{anne-sophiedelcourHommeSousPilule,
  title = {L'homme sous pilule},
  author = {{Anne-Sophie Delcour} and {Lucymacaroni}},
  publisher = {{MARAbulles}},
  isbn = {978-2-501-14694-4},
  langid = {french},
  pagetotal = {175}
}

@misc{associationfrancaisedurologieVasectomieContraceptive2012,
  title = {Vasectomie Contraceptive},
  author = {{Association Française d'Urologie}},
  date = {2012-05},
  url = {https://www.urofrance.org/sites/default/files/vasectomie_1.pdf},
  urldate = {2023-05-01},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\T8R8SBB5\\vasectomie_1.pdf}
}

@article{balbachOndemandMaleContraception2023,
  title = {On-Demand Male Contraception via Acute Inhibition of Soluble Adenylyl Cyclase},
  author = {Balbach, Melanie and Rossetti, Thomas and Ferreira, Jacob and Ghanem, Lubna and Ritagliati, Carla and Myers, Robert W. and Huggins, David J. and Steegborn, Clemens and Miranda, Ileana C. and Meinke, Peter T. and Buck, Jochen and Levin, Lonny R.},
  date = {2023-02-14},
  journaltitle = {Nature Communications},
  shortjournal = {Nat Commun},
  volume = {14},
  number = {1},
  pages = {637},
  issn = {2041-1723},
  doi = {10.1038/s41467-023-36119-6},
  url = {https://www.nature.com/articles/s41467-023-36119-6},
  urldate = {2023-05-15},
  abstract = {Abstract             Nearly half of all pregnancies are unintended; thus, existing family planning options are inadequate. For men, the only choices are condoms and vasectomy, and most current efforts to develop new contraceptives for men impact sperm development, meaning that contraception requires months of continuous pretreatment. Here, we provide proof-of-concept for an innovative strategy for on-demand contraception, where a man would take a birth control pill shortly before sex, only as needed. Soluble adenylyl cyclase (sAC) is essential for sperm motility and maturation. We show a single dose of a safe, acutely-acting sAC inhibitor with long residence time renders male mice temporarily infertile. Mice exhibit normal mating behavior, and full fertility returns the next day. These studies define sAC inhibitors as leads for on-demand contraceptives for men, and they provide in vivo proof-of-concept for previously untested paradigms in contraception; on-demand contraception after just a single dose and pharmacological contraception for men.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KMK2FY5T\\Balbach et al. - 2023 - On-demand male contraception via acute inhibition .pdf}
}

@article{CesHommesQui2023,
  entrysubtype = {newspaper},
  title = {Ces hommes qui ont choisi la vasectomie : « Notre sexualité est plus spontanée et plus sereine »},
  shorttitle = {Ces hommes qui ont choisi la vasectomie},
  date = {2023-04-10},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/parentalite/article/2023/04/10/ces-hommes-qui-ont-choisi-la-vasectomie-notre-sexualite-est-plus-spontanee-et-plus-sereine_6168906_6145697.html},
  urldate = {2023-04-11},
  abstract = {Cette méthode de stérilisation masculine reste marginale en France, bien qu’en hausse. Répartition de la charge contraceptive, refus de procréer dans un monde troublé… Les motivations sont diverses, et les regrets peu nombreux.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\83FESL9D\\ces-hommes-qui-ont-choisi-la-vasectomie-notre-sexualite-est-plus-spontanee-et-plus-sereine_6168.html}
}

@inreference{CoitInterrompu2022,
  title = {Coït interrompu},
  booktitle = {Wikipédia},
  date = {2022-06-21T07:38:46Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Co%C3%AFt_interrompu&oldid=194713871},
  urldate = {2023-05-01},
  abstract = {Le coït interrompu (coitus interruptus en latin) ou méthode du retrait est une pratique sexuelle et un moyen de contraception qui consiste à interrompre le rapport sexuel vaginal juste avant l'éjaculation. L'homme retire à ce moment son pénis du vagin et l'éjaculation a alors lieu en dehors de celui-ci, évitant ainsi la fécondation. La méthode du retrait fait partie des méthodes naturelles de régulation des naissances. Bien qu'ancienne, la méthode du retrait a été largement popularisée dans les films pornographiques à partir des années 1980. En effet, à l'écran une éjaculation hors du vagin rend davantage visible cette éjaculation tout en se passant du préservatif (Débat sur l'utilisation du préservatif dans l'industrie du film pornographique). Cette méthode de contraception a néanmoins une efficacité beaucoup plus faible que les méthodes plus classiques. Elle ne protège en outre pas des infections sexuellement transmissibles. La méthode du retrait ne doit pas être confondue avec le contrôle de l'orgasme (ou edging) qui est une technique d'intensification du plaisir sexuel ni avec le déni d'orgasme qui relève des pratiques BDSM.},
  langid = {french},
  annotation = {Page Version ID: 194713871},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\P4RNRTKT\\Coït_interrompu.html}
}

@online{CoitInterrompuWikipedia,
  title = {Coït Interrompu — {{Wikipédia}}},
  url = {https://fr.wikipedia.org/wiki/Co%C3%AFt_interrompu?oldformat=true},
  urldate = {2023-05-01},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KIERFDXZ\\Coït_interrompu.html}
}

@online{ContraceptionChezHomme2019,
  title = {Contraception chez l’homme},
  date = {2019-09},
  url = {https://www.has-sante.fr/jcms/c_1757909/fr/contraception-chez-l-homme},
  urldate = {2023-02-22},
  abstract = {Cette fiche mémo, fondée sur les recommandations les plus récentes, fait partie d’un ensemble de fiches mémo concernant la contraception et complète plusieurs documents sur ce thème produits par la HAS. Elle est un outil pour le professionnel de santé afin de mieux aider les femmes/les hommes à trouver la méthode de contraception qui leur convient le mieux à une période donnée de leur vie.},
  langid = {french},
  organization = {{Haute Autorité de Santé}},
  keywords = {HAS,masculin,officiel},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\PQ56WL3J\\contraception-chez-l-homme.html}
}

@online{ContraceptionHormonaleMasculine2016,
  title = {Contraception hormonale masculine : des résultats prometteurs},
  shorttitle = {Contraception hormonale masculine},
  date = {2016-11-02T18:05:05+01:00},
  url = {https://sante.lefigaro.fr/article/contraception-hormonale-masculine-des-resultats-prometteurs/},
  urldate = {2023-05-08},
  abstract = {Une méthode de contraception par injection d’hormones s’est révélée efficace pour 96\% des volontaires d’un essai commandé par l’OMS.},
  langid = {ISO639-2 fre},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\SHVTMIPC\\contraception-hormonale-masculine-des-resultats-prometteurs.html}
}

@online{ContraceptionMasculine,
  title = {La Contraception Masculine},
  url = {https://questionsexualite.fr/choisir-sa-contraception/ma-contraception-et-moi/contraception-masculine-comment-ca-marche},
  urldate = {2023-03-02},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\9ERTACE7\\contraception-masculine-comment-ca-marche.html}
}

@article{ContraceptionMasculineArretez2022,
  title = {contraception masculine arrêtez de vous dorer la pilule !},
  date = {2022-08-23},
  journaltitle = {Libération},
  pages = {1},
  url = {https://nouveau.europresse.com/Link/BUCOMPIEGNET_2/news%C2%B720220823%C2%B7LI%C2%B7181143014},
  abstract = {Appel Libération» demande aux pouvoirs publics et aux laboratoires de développer de vraies solutions pour que la  contraception soit autant une affaire d'hommes que de femmes. pages 2-5  ...},
  langid = {FRA},
  annotation = {Context Object: ctx\_ver=Z39.88-2004\&rft\_val\_fmt=info\%3Aofi\%2Ffmt\%3Akev\%3Amtx\%3Ajournal\&rft.genre=article\&rft.atitle=contraception\%20masculine\%20arr\%c3\%aatez\%20de\%20vous\%20dorer\%20la\%20pilule\%20!\&rft.jtitle=Lib\%c3\%a9ration\&rft.title=Lib\%c3\%a9ration\&rft.description=Appel\%20Lib\%c3\%a9ration\%c2\%bb\%20demande\%20aux\%20pouvoirs\%20publics\%20et\%20aux\%20laboratoires\%20de\%20d\%c3\%a9velopper\%20de\%20vraies\%20solutions\%20pour\%20que\%20la\%20\%20contraception\%20soit\%20autant\%20une\%20affaire\%20d\%27hommes\%20que\%20de\%20femmes.\%20pages\%202-5\%20\%20...\&rft.date=2022-08-23\&rft.language=FRA\&rft.spage=1\&rft.epage=1\&rft\_id=https://nouveau.europresse.com/Link/BUCOMPIEGNET\_2/news\%c2\%b720220823\%c2\%b7LI\%c2\%b7181143014},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KQFWN8YR\\6.html}
}

@article{ContraceptionSeDecline1982,
  entrysubtype = {newspaper},
  title = {La contraception se décline au masculin},
  date = {1982-02-27},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/archives/article/1982/02/27/la-contraception-se-decline-au-masculin_2885260_1819218.html},
  urldate = {2023-03-06},
  abstract = {Un groupe de dix hommes a commencé, en mars 1981, à Lyon, une expérience contraceptive hormonale. Peu avant la fin de leur},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\IV3YEYMP\\la-contraception-se-decline-au-masculin_2885260_1819218.html}
}

@online{ContraceptionsMasculinesCa,
  title = {Les contraceptions "masculines" ça existe ? Et oui !!},
  shorttitle = {Les contraceptions "masculines" ça existe ?},
  url = {https://www.planning-familial.org/fr/le-planning-familial-de-gironde-33/contraception/les-contraceptions-masculines-ca-existe-et-oui},
  urldate = {2023-03-02},
  langid = {french},
  organization = {{Le planning familial}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KQMX7C2F\\les-contraceptions-masculines-ca-existe-et-oui.html}
}

@inreference{Cryptorchidie2023,
  title = {Cryptorchidie},
  booktitle = {Wikipédia},
  date = {2023-01-31T14:49:53Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Cryptorchidie&oldid=200954426},
  urldate = {2023-03-07},
  abstract = {La cryptorchidie, appelée aussi trouble de la migration du testicule, ou plus communément testicule mal descendu, est l'absence d'un ou des deux testicules dans le scrotum (position normale introscrotale chez l'homme et chez les animaux à testicules externes). Elle inclut l’ectopie testiculaire, qui est l'insertion du testicule dans un autre endroit, hors des bourses et de son trajet normal, en raison d'un arrêt de la migration du testicule lors de son trajet de descente ; entre la région lombaire où il se forme et son emplacement naturel dans le scrotum.  Le testicule est dit ectopique s'il se trouve au niveau crural ou plus haut si sa descente a été bloquée. Ces deux anomalies, notamment si associées à un hypospadias ou micropénis peuvent être un des éléments du syndrome de dysgénésie testiculaire. Dans certains cas, il peut y avoir doute sur le sexe de l'individu (« ambiguïté sexuelle » ou intersexe)},
  langid = {french},
  annotation = {Page Version ID: 200954426},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\Z2E2KGA3\\Cryptorchidie.html}
}

@inreference{Cryptorchidie2023a,
  title = {Cryptorchidie},
  booktitle = {Wikipédia},
  date = {2023-04-28T13:14:34Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Cryptorchidie&oldid=203755606},
  urldate = {2023-05-18},
  abstract = {La cryptorchidie, appelée aussi trouble de la migration du testicule, ou plus communément testicule mal descendu, est l'absence d'un ou des deux testicules dans le scrotum (position normale introscrotale chez l'homme et chez les animaux à testicules externes). Elle inclut l’ectopie testiculaire, qui est l'insertion du testicule dans un autre endroit, hors des bourses et de son trajet normal, en raison d'un arrêt de la migration du testicule lors de son trajet de descente ; entre la région lombaire où il se forme et son emplacement naturel dans le scrotum.  Le testicule est dit ectopique s'il se trouve au niveau crural ou plus haut si sa descente a été bloquée. Ces deux anomalies, notamment si associées à un hypospadias ou micropénis peuvent être un des éléments du syndrome de dysgénésie testiculaire. Dans certains cas, il peut y avoir doute sur le sexe de l'individu (« ambiguïté sexuelle » ou intersexe)},
  langid = {french},
  annotation = {Page Version ID: 203755606},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\NKZ56EIB\\Cryptorchidie.html}
}

@online{CryptorchidieOuTesticule,
  title = {Cryptorchidie ou testicule non descendu : diagnostic et évolution},
  shorttitle = {Cryptorchidie ou testicule non descendu},
  url = {https://www.ameli.fr/assure/sante/themes/cryptorchidie-testicule-non-descendu-ectopie-testiculaire/diagnostic-evolution},
  urldate = {2023-05-18},
  abstract = {Le diagnostic du testicule non descendu repose sur la palpation des bourses du petit garçon à la naissance et au cours de ses premiers mois de vie.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\PQXQVHDP\\diagnostic-evolution.html}
}

@inreference{Cryptorchidism2023,
  title = {Cryptorchidism},
  booktitle = {Wikipedia},
  date = {2023-02-07T22:35:29Z},
  url = {https://en.wikipedia.org/w/index.php?title=Cryptorchidism&oldid=1138076354},
  urldate = {2023-05-18},
  abstract = {Cryptorchidism, also known as undescended testis, is the failure of one or both testes to descend into the scrotum. The word is from Greek κρυπτός (kryptos) 'hidden' and ὄρχις (orchis) 'testicle'. It is the most common birth defect of the male genital tract. About 3\% of full-term and 30\% of premature infant boys are born with at least one undescended testis. However, about 80\% of cryptorchid testes descend by the first year of life (the majority within three months), making the true incidence of cryptorchidism around 1\% overall. Cryptorchidism may develop after infancy, sometimes as late as young adulthood, but that is exceptional. Cryptorchidism is distinct from monorchism, the condition of having only one testicle. Though the condition may occur on one or both sides, it more commonly affects the right testis.A testis absent from the normal scrotal position may be: Anywhere along the "path of descent" from high in the posterior (retroperitoneal) abdomen, just below the kidney, to the inguinal ring In the inguinal canal Ectopic, having "wandered" from the path of descent, usually outside the inguinal canal and sometimes even under the skin of the thigh, the perineum, the opposite scrotum, or the femoral canal Undeveloped (hypoplastic) or severely abnormal (dysgenetic) Missing (also see anorchia).About two-thirds of cases without other abnormalities are unilateral; most of the other third involve both testes. In 90\% of cases, an undescended testis can be felt in the inguinal canal. In a small minority of cases, missing testes may be found in the abdomen or appear to be nonexistent (truly "hidden"). Undescended testes are associated with reduced fertility, increased risk of testicular germ-cell tumors, and psychological problems when fully-grown. Undescended testes are also more susceptible to testicular torsion (and subsequent infarction) and inguinal hernias. Without intervention, an undescended testicle will usually descend during the first year of life, but to reduce these risks, undescended testes can be brought into the scrotum in infancy by a surgical procedure called an orchiopexy.Although cryptorchidism nearly always refers to congenital absence or maldescent, a testis observed in the scrotum in early infancy can occasionally "reascend" (move back up) into the inguinal canal. A testis that can readily move or be moved between the scrotum and canal is referred to as retractile. Cryptorchidism, hypospadias, testicular cancer, and poor semen quality make up the syndrome known as testicular dysgenesis syndrome.},
  langid = {english},
  annotation = {Page Version ID: 1138076354},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\44P22FZB\\Cryptorchidism.html}
}

@article{decraenPlacebosPlaceboEffects1999,
  title = {Placebos and Placebo Effects in Medicine: Historical Overview},
  shorttitle = {Placebos and Placebo Effects in Medicine},
  author = {De Craen, Anton J M and Kaptchuk, Ted J and Tijssen, Jan G P and Kleijnen, J},
  date = {1999-10},
  journaltitle = {Journal of the Royal Society of Medicine},
  shortjournal = {J R Soc Med},
  volume = {92},
  number = {10},
  pages = {511--515},
  issn = {0141-0768, 1758-1095},
  doi = {10.1177/014107689909201005},
  url = {http://journals.sagepub.com/doi/10.1177/014107689909201005},
  urldate = {2023-03-10},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\DEHICDUM\\De Craen et al. - 1999 - Placebos and placebo effects in medicine historic.pdf}
}

@video{denisvanwaerebekeJamesOuRoman2018,
  entrysubtype = {video},
  title = {James Ou Le Roman d'un Médicament},
  editora = {{Denis van Waerebeke} and {Jimmy Audoin} and {Ruelgo} and {Vicent Bordelais} and {Claire lise} and {Carine Leblanc} and {Martine Zwerin}},
  editoratype = {scriptwriter},
  date = {2018-11-15},
  url = {https://www.youtube.com/watch?v=DtuHTgCN68Y},
  urldate = {2023-03-10},
  abstract = {Cette molécule-là ira loin ! Sélectionnée parmi des milliers de molécules, James (c'est son nom) est passée à la moulinette des essais chimiques, puis thérapeutiques... Un protocole hyper rigoureux raconté avec clarté et humour.}
}

@online{DeveloppementMedicamentInserm,
  title = {Développement du médicament - Inserm, La science pour la santé},
  url = {https://www.inserm.fr/dossier/medicament-developpement/},
  urldate = {2023-03-10},
  abstract = {Phase préclinique, clinique, obtention de l’autorisation de mise sur le marché… Près de 15 ans sont nécessaires pour qu’une molécule d’intérêt thérapeutique devienne un « vrai médicament » (hors dispositifs médicaux). Un parcours long et très réglementé qui aura raison de nombreuses molécules candidates se révélant finalement mal tolérées ou…},
  langid = {french},
  organization = {{Inserm}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\JX7NXESD\\medicament-developpement.html}
}

@online{DocumentSansTitre,
  title = {Document sans titre},
  url = {https://docs.google.com/document/u/0/d/1PS4dyNbeTdl8silYYTTwjHrqAgZ6Kz1Oxr2Uqg8qU-Y/edit?usp=embed_facebook},
  urldate = {2023-03-15},
  langid = {french},
  organization = {{Google Docs}}
}

@online{EfficaciteMoyensContraceptifs,
  title = {Efficacité des moyens contraceptifs},
  url = {https://www.ameli.fr/assure/sante/themes/contraception/efficacite-moyens-contraceptifs},
  urldate = {2023-05-01},
  abstract = {Aucun moyen contraceptif n’est efficace à 100 \%. On distingue l’efficacité théorique (indice de Pearl) et l’efficacité pratique.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\LLDNEMVD\\efficacite-moyens-contraceptifs.html}
}

@misc{flegmusPreservatifMasculinEnroule2023,
  title = {Préservatif masculin enroulé},
  author = {{Flegmus}},
  date = {2023-04-20T19:08:19Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Pr%C3%A9servatif&oldid=203527478},
  urldate = {2023-05-01},
  abstract = {Le préservatif ou condom (ou capote, plus familier, en Suisse, au Québec et en France) est un étui mince et souple, imperméable au sang, au sperme ainsi qu'aux sécrétions vaginales et péniennes, fabriqué en latex ou en polyuréthane. Il en existe deux types : le préservatif externe (masculin) et le préservatif interne (féminin). Le premier est aussi nommé plus familièrement « capote » en français européen. Le préservatif s'avère être très efficace pour empêcher la transmission des infections sexuellement transmissibles (IST) par les sécrétions vaginales, péniennes et le sperme mais n'offre pas de protection face aux IST présentes sur les surfaces cutanées de la zone génitale. Ainsi le préservatif, correctement utilisé lors d'une relation sexuelle avec pénétration, est le seul contraceptif qui protège de la transmission du VIH et de l'hépatite B. Il ne constitue en revanche pas une protection efficace contre d'autres IST occasionnant un nombre important de décès, comme la syphilis (30\% de protection seulement) ou encore le papillomavirus humain , responsable de plusieurs types de cancers dont le cancer du col de l'utérus et contre lequel seule la vaccination s'avère efficace. Enfin, il ne permet pas non plus de se protéger contre l'herpès génital responsable de conséquences psychologiques et sociales importantes pour la personne atteinte et dont la transmission au fœtus durant l'accouchement, appelée herpès néonatal, occasionne une importante mortalité et des séquelles lourdes.},
  langid = {french},
  annotation = {Page Version ID: 203527478},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\U2Z6AFKT\\Préservatif.html}
}

@article{freeMaleContraceptionPrescription,
  title = {Male {{Contraception Without Prescription}}},
  author = {Free, Michael J and Alexander, Nancy J},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\35CST9NT\\Free et Alexander - Male Contraception Without Prescription.pdf}
}

@article{GratuiteContraceptionPour2021,
  entrysubtype = {newspaper},
  title = {La gratuité de la contraception pour les femmes de 18 à 25 ans, une mesure adoptée à l’Assemblée nationale},
  date = {2021-10-23},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/sante/article/2021/10/23/contraception-l-assemblee-nationale-adopte-a-l-unanimite-la-gratuite-pour-les-femmes-de-18-a-25-ans_6099612_1651302.html},
  urldate = {2023-04-05},
  abstract = {Trois millions de jeunes femmes sont potentiellement concernées par ce dispositif qui entrera en vigueur le 1er~janvier~2022.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\REZUBD22\\contraception-l-assemblee-nationale-adopte-a-l-unanimite-la-gratuite-pour-les-femmes-de-18-a-25.html}
}

@article{guerinContraceptionMasculineHormonale1996,
  title = {Contraception masculine hormonale},
  author = {Guerin, J. F.},
  date = {1996-09},
  journaltitle = {Andrologie},
  shortjournal = {Androl.},
  volume = {6},
  number = {3},
  pages = {259--265},
  issn = {1166-2654, 1760-5377},
  doi = {10.1007/BF03035279},
  url = {http://link.springer.com/10.1007/BF03035279},
  urldate = {2023-05-08},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\NNBEY3DJ\\Guerin - 1996 - Contraception masculine hormonale.pdf}
}

@book{guillaumedaudinContraceptesEnqueteDernier2022,
  title = {Les contraceptés enquête sur le dernier tabou},
  author = {{Guillaume Daudin} and {Stéphane Jourdain}},
  editora = {{Caroline Lee}},
  editoratype = {collaborator},
  date = {2022-03},
  publisher = {{Steinkis}},
  isbn = {978-2-36846-430-4},
  langid = {french},
  pagetotal = {143}
}

@inreference{HeatbasedContraception2023,
  title = {Heat-Based Contraception},
  booktitle = {Wikipedia},
  date = {2023-05-09T23:50:04Z},
  url = {https://en.wikipedia.org/w/index.php?title=Heat-based_contraception&oldid=1154055159},
  urldate = {2023-05-17},
  abstract = {An alternative male contraceptive method involves heating the testicles so that they cannot produce sperm.  Sperm are best produced at a temperature slightly below body temperature. The muscles around a male's scrotum involuntarily tighten if the man's body temperature drops, and they loosen, allowing the testes to hang, if the body temperature rises. This is the body's way of keeping the sperm at an ideal temperature. This means that sperm production can be disrupted with increased temperature.  Some suggest exposure to high temperatures (116 °F equal to 47 °C) can affect fertility for months.Male thermal contraceptive methods (MTC) derive their effectiveness from the alteration of the thermoregulatory function of the scrotum. When this function is altered – by wearing tight underwear, being exposed to a high outside temperature, or by developing a fever, fertility may be impaired. Methods used include hot water applied to the scrotum, heat generated by ultrasound, and artificial cryptorchidism (holding the testicles inside the abdomen) using specialized briefs.  One of the initial experiments resulted in partial infertility lasting more than four years. Initial experiments suggest it is effective and safe, though there have not been long-term studies to determine if it has any side effects on the body after reversal.},
  langid = {english},
  annotation = {Page Version ID: 1154055159},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\RFK8HH4E\\Heat-based_contraception.html}
}

@article{heinemannAttitudesMaleFertility2005,
  title = {Attitudes toward Male Fertility Control: Results of a Multinational Survey on Four Continents},
  shorttitle = {Attitudes toward Male Fertility Control},
  author = {Heinemann, Klaas and Saad, Farid and Wiesemes, Martin and White, Steven and Heinemann, Lothar},
  date = {2005-02-01},
  journaltitle = {Human Reproduction},
  volume = {20},
  number = {2},
  pages = {549--556},
  issn = {1460-2350, 0268-1161},
  doi = {10.1093/humrep/deh574},
  url = {http://academic.oup.com/humrep/article/20/2/549/603220/Attitudes-toward-male-fertility-control-results-of},
  urldate = {2023-02-22},
  abstract = {BACKGROUND: Following extensive research activity to develop an effective agent to control male fertility, such a product may be available for use within ,5 years. However, little is known concerning contraceptive knowledge, desires and attitudes of men in different countries, and their acceptance of male fertility control (MFC). METHODS: A survey of {$>$} 9000 males aged 18 – 50 years was performed in nine countries on four continents in 2002. The objective was to compare, on a cross-cultural basis, the knowledge, attitudes and acceptability of MFC among men and assess their willingness to use such a method. RESULTS: Between 50 and 83\% of the male respondents currently use contraceptive methods, and 55 – 81.5\% reported that both partners participate in selecting the method of contraception employed. Overall acceptance of hormonal MFC was high ({$>$}55\%), with 28.5– 71.4\% of survey participants of various nationalities expressing the willingness to use such a method. CONCLUSION: While MFC appears to be well accepted overall, the willingness to use this type of contraception varies widely between differing population groups. The specific characteristics and profile of any MFC product will have to be carefully evaluated to accurately assess its acceptance, both by men and their female partners.},
  langid = {english},
  keywords = {article,avis,masculin},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\F23P9W8X\\Heinemann et al. - 2005 - Attitudes toward male fertility control results o.pdf}
}

@online{huetMeetPioneersTurning2023,
  title = {Meet the Pioneers Turning Birth Control into a Male Affair},
  author = {Huet, Natalie},
  date = {2023-04-03},
  url = {https://www.euronews.com/next/2023/04/03/future-birth-control-couples-testing-experimental-male-contraceptives-nestorone-gel},
  urldate = {2023-04-05},
  abstract = {From homemade jockstraps to a shoulder gel that slashes sperm counts, these couples are testing new male contraceptives to better share the burden of birth control.},
  langid = {english},
  organization = {{euronews}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\9G3MENF8\\future-birth-control-couples-testing-experimental-male-contraceptives-nestorone-gel.html}
}

@inreference{HypothalamicPituitaryGonadal2022,
  title = {Hypothalamic–Pituitary–Gonadal Axis},
  booktitle = {Wikipedia},
  date = {2022-09-08T08:18:14Z},
  url = {https://en.wikipedia.org/w/index.php?title=Hypothalamic%E2%80%93pituitary%E2%80%93gonadal_axis&oldid=1109152185},
  urldate = {2023-05-08},
  abstract = {The hypothalamic–pituitary–gonadal axis (HPG axis, also known as the hypothalamic–pituitary–ovarian/testicular axis) refers to the hypothalamus, pituitary gland, and gonadal glands as if these individual endocrine glands were a single entity. Because these glands often act in concert, physiologists and endocrinologists find it convenient and descriptive to speak of them as a single system. The HPG axis plays a critical part in the development and regulation of a number of the body's systems, such as the reproductive and immune systems. Fluctuations in this axis cause changes in the hormones produced by each gland and have various local and systemic effects on the body. The axis controls development, reproduction, and aging in animals. Gonadotropin-releasing hormone (GnRH) is secreted from the hypothalamus by GnRH-expressing neurons. The anterior portion of the pituitary gland produces luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and the gonads produce estrogen and testosterone. In oviparous organisms (e.g. fish, reptiles, amphibians, birds), the HPG axis is commonly referred to as the hypothalamus-pituitary-gonadal-liver axis (HPGL-axis) in females. Many egg-yolk and chorionic proteins are synthesized heterologously in the liver, which are necessary for ovocyte growth and development. Examples of such necessary liver proteins are vitellogenin and choriogenin. The HPA, HPG, and HPT axes are three pathways in which the hypothalamus and pituitary direct neuroendocrine function.},
  langid = {english},
  annotation = {Page Version ID: 1109152185},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\DEBUWZ28\\Hypothalamic–pituitary–gonadal_axis.html}
}

@online{lachaudEgaliteFautPromouvoir2021,
  title = {Égalité : il faut promouvoir la contraception masculine},
  shorttitle = {Égalité},
  author = {Lachaud, Bastien},
  date = {2021-09-21T18:06:11+00:00},
  url = {https://bastienlachaud.fr/2021/09/21/egalite-promouvoir-contraception-masculine/},
  urldate = {2023-04-05},
  abstract = {La contraception est une affaire de partenaires, sa responsabilité n'incombe pas aux femmes. Il faut promouvoir la contraception masculine.},
  langid = {french},
  organization = {{Bastien Lachaud}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KLARR8TU\\egalite-promouvoir-contraception-masculine.html}
}

@video{leblobContraceptionMasculineOu2021,
  entrysubtype = {video},
  title = {Contraception Masculine : Où En Est-on ? | {{Reportage}}},
  shorttitle = {Contraception Masculine},
  editor = {{Le Blob}},
  editortype = {director},
  date = {2021-11-29},
  url = {https://www.youtube.com/watch?v=8i6Z2BAaDsE},
  urldate = {2023-05-14},
  abstract = {Autorisée depuis plus d'un demi-siècle en France, la contraception est très majoritairement le fait des femmes. Alors, à quand la contraception masculine ? Où en sont les recherches dans ce domaine ? Réalisation : Anaïs Poncet Production : Universcience 2021 Tous nos films sur https://LeBlob.fr}
}

@article{lohiyaRISUGIntravasalInjectable2014,
  title = {{{RISUG}}: {{An}} Intravasal Injectable Male Contraceptive},
  author = {Lohiya, N K and Alam, I and Hussain, M and Khan, S R and Ansari, A S},
  date = {2014},
  journaltitle = {INDIAN J MED RES},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\5GCT53E8\\IJMR-140-63.pdf;C\:\\Users\\esteb\\Zotero\\storage\\9D7ZDDQW\\274948_spf00001571.pdf}
}

@article{longUpdateNovelHormonal2021,
  title = {Update on {{Novel Hormonal}} and {{Nonhormonal Male Contraceptive Development}}},
  author = {Long, Jill E and Lee, Min S and Blithe, Diana L},
  date = {2021-05-13},
  journaltitle = {The Journal of Clinical Endocrinology \& Metabolism},
  volume = {106},
  number = {6},
  pages = {e2381-e2392},
  issn = {0021-972X, 1945-7197},
  doi = {10.1210/clinem/dgab034},
  url = {https://academic.oup.com/jcem/article/106/6/e2381/6108319},
  urldate = {2023-02-22},
  abstract = {Background:\hspace{0.6em}The advent of new methods of male contraception would increase contraceptive options for men and women and advance male contraceptive agency. Pharmaceutical R\&D for male contraception has been dormant since the 1990s. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has supported a contraceptive development program since 1969 and supports most ongoing hormonal male contraceptive development. Nonhormonal methods are in earlier stages of development.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\98B4LLZG\\Long et al. - 2021 - Update on Novel Hormonal and Nonhormonal Male Cont.pdf}
}

@online{MaladiesInfectionsSexuellement,
  title = {Maladies et infections sexuellement transmissibles},
  url = {https://www.ameli.fr/assure/sante/themes/mst-ist/maladies-infections-sexuellement-transmissibles},
  urldate = {2023-05-01},
  abstract = {Les infections sexuellement transmissibles ou IST sont des infections dues à des bactéries, virus et parasites, et transmises par voie sexuelle.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\TCG7WJMJ\\maladies-infections-sexuellement-transmissibles.html}
}

@article{manettiUpdateMaleHormonal2010,
  title = {Update on {{Male Hormonal Contraception}}: {{Is}} the {{Vasectomy}} in {{Jeopardy}}?},
  shorttitle = {Update on {{Male Hormonal Contraception}}},
  author = {Manetti, G J and Honig, S C},
  date = {2010-05},
  journaltitle = {International Journal of Impotence Research},
  shortjournal = {Int J Impot Res},
  volume = {22},
  number = {3},
  pages = {159--170},
  issn = {0955-9930, 1476-5489},
  doi = {10.1038/ijir.2010.2},
  url = {https://www.nature.com/articles/ijir20102},
  urldate = {2023-02-22},
  langid = {english},
  keywords = {masculine}
}

@article{manettiUpdateMaleHormonal2010a,
  title = {Update on {{Male Hormonal Contraception}}: {{Is}} the {{Vasectomy}} in {{Jeopardy}}?},
  shorttitle = {Update on {{Male Hormonal Contraception}}},
  author = {Manetti, G J and Honig, S C},
  date = {2010-05},
  journaltitle = {International Journal of Impotence Research},
  shortjournal = {Int J Impot Res},
  volume = {22},
  number = {3},
  pages = {159--170},
  issn = {0955-9930, 1476-5489},
  doi = {10.1038/ijir.2010.2},
  url = {https://www.nature.com/articles/ijir20102},
  urldate = {2023-02-22},
  langid = {english},
  keywords = {article,masculine}
}

@article{manettiUpdateMaleHormonal2010b,
  title = {Update on {{Male Hormonal Contraception}}: {{Is}} the {{Vasectomy}} in {{Jeopardy}}?},
  shorttitle = {Update on {{Male Hormonal Contraception}}},
  author = {Manetti, G J and Honig, S C},
  date = {2010-05},
  journaltitle = {International Journal of Impotence Research},
  shortjournal = {Int J Impot Res},
  volume = {22},
  number = {3},
  pages = {159--170},
  issn = {0955-9930, 1476-5489},
  doi = {10.1038/ijir.2010.2},
  url = {https://www.nature.com/articles/ijir20102},
  urldate = {2023-02-22},
  langid = {english},
  keywords = {article,masculin},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\K4ZDUSEL\\Manetti et Honig - 2010 - Update on Male Hormonal Contraception Is the Vase.pdf}
}

@article{marlenethomasContraceptionMasculineArretez2022,
  entrysubtype = {newspaper},
  title = {Contraception masculine arrêtez de vous dorer la pilule !},
  author = {{Marlène Thomas} and {Dov Alfon} and {Viriginie Ballet} and {Camille Gévaudant}},
  date = {2022-08-23},
  journaltitle = {Libération},
  pages = {2--5},
  langid = {french}
}

@online{medisitePiluleContraceptivePour,
  title = {Pilule contraceptive pour homme : qu'est-ce que la DMAU},
  shorttitle = {Pilule contraceptive pour homme},
  author = {Médisite, La Rédaction},
  url = {https://www.medisite.fr/contraception-pilule-contraceptive-pour-homme-quest-ce-que-la-dmau.5317139.373055.html},
  urldate = {2023-05-13},
  abstract = {La contraception orale est longtemps restée exclusivement féminine. Une pilule contraceptive pour homme a récemment fait son apparition. Elle...},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\GR5ZALSD\\contraception-pilule-contraceptive-pour-homme-quest-ce-que-la-dmau.5317139.373055.html}
}

@online{MethodeThermique,
  title = {Méthode thermique |},
  url = {https://www.contraceptionmasculine.fr/la-methode-thermique/},
  urldate = {2023-05-18},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\T74WP5CZ\\la-methode-thermique.html}
}

@article{mieussetHyperthermiaHumanSpermatogenesis1987,
  title = {Hyperthermia and Human Spermatogenesis: Enhancement of the Inhibitory Effect Obtained by ‘Artificial Cryptorchidism’},
  shorttitle = {Hyperthermia and Human Spermatogenesis},
  author = {Mieusset, R. and Bujan, L. and Mansat, Arlette and Pontonnier, F. and Grandjean, Hélène},
  date = {1987-08},
  journaltitle = {International Journal of Andrology},
  shortjournal = {Int J Androl},
  volume = {10},
  number = {4},
  pages = {571--580},
  issn = {0105-6263, 1365-2605},
  doi = {10.1111/j.1365-2605.1987.tb00356.x},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.1987.tb00356.x},
  urldate = {2023-03-07},
  abstract = {Decreased sperm count and motility were observed in men after induction of local testicular hyperthermia by raising the testicles into the inguinal canal during the day in adult volunteers. A similar technique in which the testicles were better maintained in the inguinal canal resulted in more marked suppression of spermatogenesis. As assessed by the total motile sperm count, the mean inhibitory effect of hyperthermia was at least 97\% after 2 months using this technique. This effect of ‘artificial cryptorchidism’ may be of practical interest in the manipulation of male fertility.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KY3KV885\\Mieusset et al. - 1987 - Hyperthermia and human spermatogenesis enhancemen.pdf}
}

@article{mieussetInhibitingEffectArtificial1985,
  title = {Inhibiting Effect of Artificial Cryptorchidism on Spermatogenesis},
  author = {Mieusset, Roger and Grandjean, Hélène and Mansat, Arlette and Pontonnier, Francis},
  date = {1985-04},
  journaltitle = {Fertility and Sterility},
  shortjournal = {Fertility and Sterility},
  volume = {43},
  number = {4},
  pages = {589--594},
  issn = {00150282},
  doi = {10.1016/S0015-0282(16)48502-X},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S001502821648502X},
  urldate = {2023-03-07},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\YGCQIIBV\\Mieusset et al. - 1985 - Inhibiting effect of artificial cryptorchidism on .pdf}
}

@article{mieussetPotentialMildTesticular1994,
  title = {The Potential of Mild Testicular Heating as a Safe, Effective and Reversible Contraceptive Method for Men},
  author = {Mieusset, Roger and B'Ujan, Louis},
  date = {1994-08},
  journaltitle = {International Journal of Andrology},
  shortjournal = {Int J Androl},
  volume = {17},
  number = {4},
  pages = {186--191},
  issn = {0105-6263, 1365-2605},
  doi = {10.1111/j.1365-2605.1994.tb01241.x},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.1994.tb01241.x},
  urldate = {2023-03-07},
  abstract = {A preliminary assessment of the contraceptive efficacy of a daily mild increase (1-2OC) in testicular temperature during waking hours is reported in nine couples using two techniques of non-surgical fixation of the testes close to the inguinal canal. With technique 1, immobilization was achieved by passing the penis and the empty scrotum through a hole made in close-fitting underwear; there was one pregnancy, h m a man who stopped the heating after 7 weeks, for 42 cycles of exposure in three couples. With technique 2, immobilization was achieved by adding a ring of soft material surrounding the hole in the underwear; there was no pregnancy for 117 cycles of exposure in six couples. Reversibility and safety were assessed. These preliminary results suggest that a daily mild increase in testicular temperature could be a potential contraceptive method for men.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\A2N8LD5U\\Mieusset et B'Ujan - 1994 - The potential of mild testicular heating as a safe.pdf}
}

@article{mieussetPotentialMildTesticular1994a,
  title = {The Potential of Mild Testicular Heating as a Safe, Effective and Reversible Contraceptive Method for Men},
  author = {Mieusset, Roger and B'Ujan, Louis},
  date = {1994-08},
  journaltitle = {International Journal of Andrology},
  shortjournal = {Int J Androl},
  volume = {17},
  number = {4},
  pages = {186--191},
  issn = {0105-6263, 1365-2605},
  doi = {10.1111/j.1365-2605.1994.tb01241.x},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.1994.tb01241.x},
  urldate = {2023-03-07},
  abstract = {A preliminary assessment of the contraceptive efficacy of a daily mild increase (1-2OC) in testicular temperature during waking hours is reported in nine couples using two techniques of non-surgical fixation of the testes close to the inguinal canal. With technique 1, immobilization was achieved by passing the penis and the empty scrotum through a hole made in close-fitting underwear; there was one pregnancy, h m a man who stopped the heating after 7 weeks, for 42 cycles of exposure in three couples. With technique 2, immobilization was achieved by adding a ring of soft material surrounding the hole in the underwear; there was no pregnancy for 117 cycles of exposure in six couples. Reversibility and safety were assessed. These preliminary results suggest that a daily mild increase in testicular temperature could be a potential contraceptive method for men.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\T8SNNHQY\\Mieusset et B'Ujan - 1994 - The potential of mild testicular heating as a safe.pdf}
}

@online{MuscleCremasterWikipedia,
  title = {Muscle Crémaster — {{Wikipédia}}},
  url = {https://fr.wikipedia.org/wiki/Muscle_cr%C3%A9master?oldformat=true},
  urldate = {2023-05-17},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\SFPMJEQ3\\Muscle_crémaster.html}
}

@online{NoticePatientANDROGEL,
  title = {Notice Patient - {{ANDROGEL}} 16,2 Mg/g, Gel - {{Base}} de Données Publique Des Médicaments},
  url = {https://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=68097237&typedoc=N},
  urldate = {2023-05-14},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KDCJTDXF\\affichageDoc.html}
}

@misc{NoticeUtilisationPdf2022,
  title = {Notice d'utilisation.Pdf},
  date = {2022-08-11},
  url = {https://thoreme.com/wp-content/uploads/2022/10/Notice-dutilisation-ANDRO-SWITCH-10-2022.pdf},
  urldate = {2023-05-18},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\AR7Y73D6\\Notice-dutilisation-ANDRO-SWITCH-10-2022.pdf}
}

@online{PreservatifWikipedia,
  title = {Préservatif — {{Wikipédia}}},
  url = {https://fr.wikipedia.org/wiki/Pr%C3%A9servatif?oldformat=true},
  urldate = {2023-05-01},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\PJSPBZLK\\Préservatif.html}
}

@online{PreventionIST,
  title = {Prévention des IST},
  url = {https://www.ameli.fr/assure/sante/themes/mst-ist/prevention},
  urldate = {2023-05-01},
  abstract = {La prévention des infections sexuellement transmissibles passe principalement par l’utilisation du préservatif et pour certaines par la vaccination.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\EQVRTG5A\\prevention.html}
}

@online{Question41326Assemblee,
  title = {Question N°41326 - {{Assemblée}} Nationale},
  url = {https://questions.assemblee-nationale.fr/q15/15-41326QE.htm},
  urldate = {2023-04-05}
}

@online{Question41326Assembleea,
  title = {Question N°41326 - {{Assemblée}} Nationale},
  url = {https://questions.assemblee-nationale.fr/q15/15-41326QE.htm},
  urldate = {2023-04-05}
}

@inreference{Risug2021,
  title = {Risug},
  booktitle = {Wikipédia},
  date = {2021-02-11T07:52:00Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Risug&oldid=179797257},
  urldate = {2023-02-22},
  abstract = {Le  RISUG  (Reversible Inhibition of Sperm Under Guidance), anciennement dénommé SMA,  est le nom de développement d'un contraceptif masculin développé à l'Institut indien de technologie de Kharagpur en Inde par le Dr Sujoy K. Guha. Il est actuellement en phase III des essais cliniques[réf. nécessaire] (visant à établir l'efficacité et la tolérance du contraceptif masculin). Ce dernier a été breveté en Inde, en Chine, au Bangladesh, aux États-Unis et au Canada.},
  langid = {french},
  keywords = {masculin},
  annotation = {Page Version ID: 179797257},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\R5PKC8MU\\Risug.html}
}

@misc{santepublicfranceChoisirSaContraception2019,
  title = {Choisir sa contraception},
  author = {{Sante public france}},
  editora = {{Service du droit des femmes et de l’égalité} and {Association française pour la contraception} and {Mouvement français pour le planning familial} and {Centre régional d’information et de prévention du sida Île-de-France}},
  editoratype = {collaborator},
  date = {2019-10},
  url = {https://www.santepubliquefrance.fr/content/download/461303/3575583?version=1},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\A5YBTMQ9\\274948_spf00001571.pdf}
}

@article{SexualiteHommesAbsents2023,
  entrysubtype = {newspaper},
  title = {Sexualité : les hommes absents de la conversation},
  shorttitle = {Sexualité},
  date = {2023-04-02},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/m-perso/article/2023/04/02/sexualite-les-hommes-absents-de-la-conversation_6167920_4497916.html},
  urldate = {2023-04-05},
  abstract = {CHRONIQUE. Rares sont les experts à s’exprimer sur les questions sexuelles ou de genre, constate Maïa Mazaurette, la chroniqueuse de «~La Matinale~», qui déplore cette sous-représentation~: la société dans son ensemble bénéficierait de paroles masculines libres et informées.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\Y9XDVGF2\\sexualite-les-hommes-absents-de-la-conversation_6167920_4497916.html}
}

@online{SterilisationViseeContraceptive,
  title = {Stérilisation à visée contraceptive},
  url = {https://www.ameli.fr/assure/sante/themes/contraception/sterilisation-contraceptive-homme-femme},
  urldate = {2023-05-01},
  abstract = {La stérilisation à visée contraceptive ne peut être pratiquée que chez une personne majeure (homme ou femme). C'est une méthode permanente et irréversible.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\9L3CVE25\\sterilisation-contraceptive-homme-femme.html}
}

@article{tcherdukianContraceptionMasculineQuelles2020,
  title = {Contraception masculine : quelles (r)évolutions ?},
  shorttitle = {Contraception masculine},
  author = {Tcherdukian, J. and Mieusset, R. and Soufir, J.-C. and Huygues, E. and Martin, T. and Karsenty, G. and Lechevalier, E. and Perrin, J.},
  date = {2020-12},
  journaltitle = {Progrès en Urologie - FMC},
  shortjournal = {Progrès en Urologie - FMC},
  volume = {30},
  number = {4},
  pages = {F105-F111},
  issn = {1761676X},
  doi = {10.1016/j.fpurol.2020.07.002},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S1761676X20300493},
  urldate = {2023-05-08},
  abstract = {Although the spectrum of women contraceptives includes 11 different methods, only 3 are commonly used by men: condoms, withdrawal, which has a high failure rate, as well as vasectomy, considered as an irreversible method. Over the past 40 years, numerous studies have been carried out to develop safe and effective hormonal and non-hormonal male contraceptives. Although their effectiveness has been proven, hormonal and thermal male contraception are still little used. The principles, protocols, effectiveness, reversibility and acceptability of these two methods are presented, as well as the practical elements for their prescription and monitoring.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\VA6SYP9Z\\Tcherdukian et al. - 2020 - Contraception masculine  quelles (r)évolutions .pdf}
}

@inreference{Testicule2023,
  title = {Testicule},
  booktitle = {Wikipédia},
  date = {2023-05-14T17:27:48Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Testicule&oldid=204241514},
  urldate = {2023-05-17},
  abstract = {Les testicules (testes) sont les gonades mâles des animaux. Ils appartiennent à l'appareil reproducteur masculin, ce sont les homologues des ovaires. Ils ont une double fonction, plus ou moins exprimée selon les périodes de la vie :  spermatogenèse (production de spermatozoïdes) ; stéroïdogenèse (fonction hormonale, active in utero lors de la différenciation sexuelle, puis brièvement dans les premiers mois suivant la naissance, puis à partir de la puberté jusqu'à la fin de la vie).La majorité des vertébrés possèdent des testicules jumelés. Chez les oiseaux, les reptiles, les poissons et les amphibies, ils sont internes (testicules intra-abdominaux). Chez les premiers mammifères, ils sont également internes (caractère plésiomorphe), en position intra-abdominale (Afrothériens, Insectivores, Siréniens). Puis ils migrent lors de l'embryogenèse (descente des testicules, descensus testiculorum) et deviennent externes, dans une poche qui s'appelle le scrotum, phénomène apparu il y a 147 millions d'années chez les mammifères thériens. Chez quelques espèces de mammifères (xénarthres, mammifères marins tels que les cétacés), l'ascension secondaire des gonades explique leurs testicules internes en position intra-abdominale.},
  langid = {french},
  annotation = {Page Version ID: 204241514},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\3CZMSBYD\\Testicule.html}
}

@article{thirumalaiDimethandroloneUndecanoateNovel2020,
  title = {Dimethandrolone {{Undecanoate}}, a {{Novel}}, {{Nonaromatizable Androgen}}, {{Increases P1NP}} in {{Healthy Men Over}} 28 {{Days}}},
  author = {Thirumalai, Arthi and Yuen, Fiona and Amory, John K and Hoofnagle, Andrew N and Swerdloff, Ronald S and Liu, Peter Y and Long, Jill E and Blithe, Diana L and Wang, Christina and Page, Stephanie T},
  date = {2020-10-22},
  journaltitle = {The Journal of Clinical Endocrinology and Metabolism},
  shortjournal = {J Clin Endocrinol Metab},
  volume = {106},
  number = {1},
  eprint = {33090208},
  eprinttype = {pmid},
  pages = {e171-e181},
  issn = {0021-972X},
  doi = {10.1210/clinem/dgaa761},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765650/},
  urldate = {2023-05-13},
  abstract = {Context Dimethandrolone undecanoate (DMAU) is being developed as a male contraceptive. Daily oral administration of DMAU, a potent androgen that is not aromatized, markedly suppresses serum testosterone (T) and estradiol (E2) in healthy men. E2 deficiency can increase bone resorption in men. Objective This work aimed to assess changes in bone turnover markers with DMAU administration in a 28-day study. Design A randomized, double-blind, placebo-controlled study was conducted. Setting This study took place at 2 academic medical centers. Participants Healthy men, age 18 to50 years (n = 81), participated. Intervention Men received 0, 100, 200, or 400 mg of oral DMAU for 28 days. Serum C-terminal telopeptide of type I collagen (CTX; bone resorption marker) and procollagen type I amino-terminal propeptide (P1NP; bone formation marker) were measured on days 1 and 28. Main Outcome Measures Changes in bone turnover markers and serum hormones over the treatment period were measured. Results On day 28, median serum T and E2 were markedly suppressed in all treatment groups vs placebo (P {$<$} .001 for both). Percentage change (\%) in serum P1NP significantly differed across treatment groups (P = .007): Serum P1NP significantly increased in the 200 mg (5\%, interquartile range [IQR] –7\% to 27\%) and 400 mg (22\%, IQR –1\% to 40\%) groups relative to placebo (–8\%, IQR –20\% to 0\%). Change (\%) in serum CTX did not differ between groups (P = .09). Conclusions DMAU administration for 28 days to healthy men leads to marked suppression of serum T and E2, yet increases P1NP, a serum marker of bone formation. Longer-term studies of the potent androgen DMAU are warranted to determine its impact on bone health in men.},
  pmcid = {PMC7765650},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\8U96AES2\\Thirumalai et al. - 2020 - Dimethandrolone Undecanoate, a Novel, Nonaromatiza.pdf}
}

@online{TousMoyensContraception2023,
  title = {Tous Les Moyens de Contraception Dans Un Tableau Comparatif.},
  date = {2023-02-22},
  url = {https://questionsexualite.fr/choisir-sa-contraception/ma-contraception-et-moi/tableau-comparatif-pour-vous-guider-dans-votre-choix-de-contraception},
  urldate = {2023-02-22},
  keywords = {comparatif,feminin,masculin,officiel},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\BI8R8L96\\tableau-comparatif-pour-vous-guider-dans-votre-choix-de-contraception.html}
}

@article{vanwerschAttitudesMaleContraceptive2012,
  title = {Attitudes towards the Male Contraceptive Pill: Psychosocial and Cultural Explanations for Delaying a Marketable Product},
  shorttitle = {Attitudes towards the Male Contraceptive Pill},
  author = {Van Wersch, A. and Eberhardt, J. and Stringer, F.},
  date = {2012-09},
  journaltitle = {Basic and Clinical Andrology},
  shortjournal = {Basic Clin. Androl.},
  volume = {22},
  number = {3},
  pages = {171--179},
  issn = {2051-4190},
  doi = {10.1007/s12610-012-0185-4},
  url = {https://bacandrology.biomedcentral.com/articles/10.1007/s12610-012-0185-4},
  urldate = {2023-05-08},
  abstract = {Even though years of research on the male contraceptive pill have been conducted, a marketable product is still absent from the arsenal of male and female products of contraception. In this paper, the following psychosocial and cultural factors have been elicited from the literature in order to reveal explanations for this delay: acceptability, trust, fear of side-effects, perceptions of contraceptive responsibility and fear of losing connotations of masculinity. Regardless of cultural variation, overall there seems to be a positive attitude towards the acceptability of male contraceptive for both males and females, especially males in stable relationships. Some indication shows that the media have played an important role in distorting the results of research regarding male and female trust. Ongoing and future researches into several projects on psychosocial and cultural factors are described.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\RTKW4IJ4\\Van Wersch et al. - 2012 - Attitudes towards the male contraceptive pill psy.pdf}
}

@online{VasectomieEstelleReversible,
  title = {La vasectomie est-elle réversible, comme le dit la série «The Office» ?},
  url = {https://www.liberation.fr/checknews/2019/07/05/la-vasectomie-est-elle-reversible-comme-le-dit-la-serie-the-office_1737961/},
  urldate = {2023-05-01},
  abstract = {La vasectomie est une méthode considérée comme définitive, car la réussite de l'opération inverse n'est pas garantie.},
  langid = {french},
  organization = {{Libération}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\NE8CR5FD\\la-vasectomie-est-elle-reversible-comme-le-dit-la-serie-the-office_1737961.html}
}

@online{VasectomieToutSavoir2017,
  title = {La vasectomie : tout savoir sur la stérilisation masculine},
  shorttitle = {La vasectomie},
  date = {2017-09-24},
  url = {https://www.passeportsante.net/fr/Maux/examens-medicaux-operations/Fiche.aspx?doc=vasectomie},
  urldate = {2023-05-01},
  abstract = {La vasectomie est une technique de stérilisation masculine considérée comme définitive. Elle consiste empêcher les spermatozoïdes d’être incorporés à l’éjaculat.},
  langid = {french},
  organization = {{https://www.passeportsante.net/}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\E5XVXINI\\Fiche.html}
}

@article{VersPiluleContraceptive2012,
  entrysubtype = {newspaper},
  title = {Vers une pilule contraceptive masculine},
  date = {2012-08-16},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/sciences/article/2012/08/16/vers-une-pilule-contraceptive-masculine_1746855_1650684.html},
  urldate = {2023-03-06},
  abstract = {Un nouveau front s'est ouvert dans la quête d'un contraceptif masculin : grâce à une petite molécule, la fabrication de spermatozoïdes a pu être bloquée de façon spécifique et réversible chez des souris.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\DJEBP4LN\\vers-une-pilule-contraceptive-masculine_1746855_1650684.html}
}

@article{waitesDevelopmentMethodsMale2003,
  title = {Development of Methods of Male Contraception: Impact of the {{World Health Organization Task Force}}},
  shorttitle = {Development of Methods of Male Contraception},
  author = {Waites, Geoffrey M.H.},
  date = {2003-07},
  journaltitle = {Fertility and Sterility},
  shortjournal = {Fertility and Sterility},
  volume = {80},
  number = {1},
  pages = {1--15},
  issn = {00150282},
  doi = {10.1016/S0015-0282(03)00577-6},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S0015028203005776},
  urldate = {2023-02-28},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KCE2L8YR\\Waites - 2003 - Development of methods of male contraception impa.pdf}
}

@article{wallachRoleTemperatureRegulation1988,
  title = {Role of Temperature in Regulation of Spermatogenesis and the Use of Heating as a Method for Contraception},
  author = {Wallach, Edward E. and Kandeel, Fouad R. and Swerdloff, Ronald S.},
  date = {1988-01-01},
  journaltitle = {Fertility and Sterility},
  shortjournal = {Fertility and Sterility},
  volume = {49},
  number = {1},
  pages = {1--23},
  issn = {0015-0282},
  doi = {10.1016/S0015-0282(16)59640-X},
  url = {https://www.sciencedirect.com/science/article/pii/S001502821659640X},
  urldate = {2023-05-17},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\EGU7PYRT\\Wallach et al. - 1988 - Role of temperature in regulation of spermatogenes.pdf;C\:\\Users\\esteb\\Zotero\\storage\\ZBCWGAAW\\S001502821659640X.html}
}

@article{wangBETBromodomainInhibitor2022,
  title = {{{BET}} Bromodomain Inhibitor {{JQ1}} Regulates Spermatid Development by Changing Chromatin Conformation in Mouse Spermatogenesis},
  author = {Wang, Xiaorong and Sang, Mengmeng and Gong, Shengnan and Chen, Zhichuan and Zhao, Xi and Wang, Guishuan and Li, Zhiran and Huang, Yingying and Chen, Shitao and Xie, Gangcai and Duan, Enkui and Sun, Fei},
  date = {2022-07},
  journaltitle = {Genes \& Diseases},
  shortjournal = {Genes \& Diseases},
  volume = {9},
  number = {4},
  pages = {1062--1073},
  issn = {23523042},
  doi = {10.1016/j.gendis.2020.12.012},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2352304221000076},
  urldate = {2023-03-06},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\GN4M6TIJ\\Wang et al. - 2022 - BET bromodomain inhibitor JQ1 regulates spermatid .pdf}
}

@online{WikiwandHypothalamicPituitary,
  title = {Wikiwand - {{Hypothalamic}}–Pituitary–Gonadal Axis},
  url = {https://wikiwand.com/en/Hypothalamic–pituitary–gonadal_axis},
  urldate = {2023-05-08},
  abstract = {The hypothalamic–pituitary–gonadal axis refers to the hypothalamus, pituitary gland, and gonadal glands as if these individual endocrine glands were a single entity. Because these glands often act in concert, physiologists and endocrinologists find it convenient and descriptive to speak of them as a single system. The HPG axis plays a critical part in the development and regulation of a number of the body's systems, such as the reproductive and immune systems. Fluctuations in this axis cause changes in the hormones produced by each gland and have various local and systemic effects on the body. The axis controls development, reproduction, and aging in animals. Gonadotropin-releasing hormone is secreted from the hypothalamus by GnRH-expressing neurons. The anterior portion of the pituitary gland produces luteinizing hormone and follicle-stimulating hormone , and the gonads produce estrogen and testosterone.},
  organization = {{Wikiwand}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\U33NAL4V\\Hypothalamic–pituitary–gonadal_axis.html}
}

@online{WikiwandPreservatif1920,
  title = {Wikiwand - {{Préservatif}}},
  date = {1920-07-31},
  url = {https://wikiwand.com/fr/Préservatif},
  urldate = {2023-05-01},
  abstract = {Le préservatif ou condom est un étui mince et souple, imperméable au sang, au sperme ainsi qu'aux sécrétions vaginales et péniennes, fabriqué en latex ou en polyuréthane. Il en existe deux types : le préservatif externe et le préservatif interne . Le premier est aussi nommé plus familièrement « capote » en français européen. Le préservatif s'avère être très efficace pour empêcher la transmission des infections sexuellement transmissibles par les sécrétions vaginales, péniennes et le sperme mais n'offre pas de protection face aux IST présentes sur les surfaces cutanées de la zone génitale. Ainsi le préservatif, correctement utilisé lors d'une relation sexuelle avec pénétration, est le seul contraceptif qui protège de la transmission du VIH et de l'hépatite B. Il ne constitue en revanche pas une protection efficace contre d'autres IST occasionnant un nombre important de décès, comme la syphilis .},
  organization = {{Wikiwand}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\AI3AI3PQ\\Préservatif.html}
}

@online{ZoteroYourPersonal,
  title = {Zotero | {{Your}} Personal Research Assistant},
  url = {https://www.zotero.org/start},
  urldate = {2023-02-22},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\LSCHTE7Z\\start.html}
}
